Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
Identifieur interne : 000427 ( Main/Exploration ); précédent : 000426; suivant : 000428Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
Auteurs : Veronica A. Bruno [Canada] ; Susan H. Fox [Canada] ; Deborah Mancini [Canada] ; Janis M. Miyasaki [Canada]Source :
- The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [ 0317-1671 ] ; 2016.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Botulinum Toxins (therapeutic use), Female, Humans, Logistic Models, Male, Middle Aged, Neurotoxins (therapeutic use), Pain Measurement, Pain, Intractable (drug therapy), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Retrospective Studies, Severity of Illness Index, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Botulinum Toxins, Neurotoxins.
- drug therapy : Pain, Intractable, Parkinson Disease.
- physiopathology : Parkinson Disease.
- Adult, Aged, Aged, 80 and over, Female, Humans, Logistic Models, Male, Middle Aged, Pain Measurement, Retrospective Studies, Severity of Illness Index, Treatment Outcome.
Abstract
Parkinson's disease (PD) and other parkinsonian syndromes are chronic, progressive neurodegenerative diseases. With advancing disease, both motor and non-motor symptoms represent a considerable burden and symptom relief and quality of life improvement become the main goal of treatment. Botulinum toxins (BTX) are an effective treatment modality for many neurological conditions.
DOI: 10.1017/cjn.2016.279
PubMed: 27514242
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000163
- to stream PubMed, to step Curation: 000163
- to stream PubMed, to step Checkpoint: 000163
- to stream Ncbi, to step Merge: 002049
- to stream Ncbi, to step Curation: 002049
- to stream Ncbi, to step Checkpoint: 002049
- to stream Main, to step Merge: 000428
- to stream Main, to step Curation: 000427
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.</title><author><name sortKey="Bruno, Veronica A" sort="Bruno, Veronica A" uniqKey="Bruno V" first="Veronica A" last="Bruno">Veronica A. Bruno</name><affiliation wicri:level="1"><nlm:affiliation>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name><affiliation wicri:level="1"><nlm:affiliation>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Mancini, Deborah" sort="Mancini, Deborah" uniqKey="Mancini D" first="Deborah" last="Mancini">Deborah Mancini</name><affiliation wicri:level="1"><nlm:affiliation>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Miyasaki, Janis M" sort="Miyasaki, Janis M" uniqKey="Miyasaki J" first="Janis M" last="Miyasaki">Janis M. Miyasaki</name><affiliation wicri:level="1"><nlm:affiliation>2University of Alberta,Edmonton,Alberta,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>2University of Alberta,Edmonton,Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27514242</idno><idno type="pmid">27514242</idno><idno type="doi">10.1017/cjn.2016.279</idno><idno type="wicri:Area/PubMed/Corpus">000163</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000163</idno><idno type="wicri:Area/PubMed/Curation">000163</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000163</idno><idno type="wicri:Area/PubMed/Checkpoint">000163</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000163</idno><idno type="wicri:Area/Ncbi/Merge">002049</idno><idno type="wicri:Area/Ncbi/Curation">002049</idno><idno type="wicri:Area/Ncbi/Checkpoint">002049</idno><idno type="wicri:doubleKey">0317-1671:2016:Bruno V:botulinum:toxin:use</idno><idno type="wicri:Area/Main/Merge">000428</idno><idno type="wicri:Area/Main/Curation">000427</idno><idno type="wicri:Area/Main/Exploration">000427</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.</title><author><name sortKey="Bruno, Veronica A" sort="Bruno, Veronica A" uniqKey="Bruno V" first="Veronica A" last="Bruno">Veronica A. Bruno</name><affiliation wicri:level="1"><nlm:affiliation>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name><affiliation wicri:level="1"><nlm:affiliation>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Mancini, Deborah" sort="Mancini, Deborah" uniqKey="Mancini D" first="Deborah" last="Mancini">Deborah Mancini</name><affiliation wicri:level="1"><nlm:affiliation>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease,Toronto Western Hospital,University Health Network,Toronto,Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Miyasaki, Janis M" sort="Miyasaki, Janis M" uniqKey="Miyasaki J" first="Janis M" last="Miyasaki">Janis M. Miyasaki</name><affiliation wicri:level="1"><nlm:affiliation>2University of Alberta,Edmonton,Alberta,Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>2University of Alberta,Edmonton,Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</title><idno type="ISSN">0317-1671</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Botulinum Toxins (therapeutic use)</term><term>Female</term><term>Humans</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Neurotoxins (therapeutic use)</term><term>Pain Measurement</term><term>Pain, Intractable (drug therapy)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Retrospective Studies</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins</term><term>Neurotoxins</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Pain, Intractable</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Pain Measurement</term><term>Retrospective Studies</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease (PD) and other parkinsonian syndromes are chronic, progressive neurodegenerative diseases. With advancing disease, both motor and non-motor symptoms represent a considerable burden and symptom relief and quality of life improvement become the main goal of treatment. Botulinum toxins (BTX) are an effective treatment modality for many neurological conditions.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Bruno, Veronica A" sort="Bruno, Veronica A" uniqKey="Bruno V" first="Veronica A" last="Bruno">Veronica A. Bruno</name></noRegion><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name><name sortKey="Mancini, Deborah" sort="Mancini, Deborah" uniqKey="Mancini D" first="Deborah" last="Mancini">Deborah Mancini</name><name sortKey="Miyasaki, Janis M" sort="Miyasaki, Janis M" uniqKey="Miyasaki J" first="Janis M" last="Miyasaki">Janis M. Miyasaki</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000427 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000427 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27514242
|texte= Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27514242" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |